AbbVie Inc
ABBV: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$997.00 | Wbxg | Zzvvygcj |
AbbVie Earnings: Strong Results and Robust Outlook Lead to Fair Value Estimate Increase
AbbVie reported strong fourth-quarter earnings and increased long-term guidance well above our expectations, and we plan to increase our fair value estimate based on the firm’s strengthening position.